SRH Total Return Fund, Inc. (NYSE:STEW – Get Free Report) Director Jacob Hemmer purchased 5,000 shares of SRH Total Return Fund stock in a transaction dated Thursday, May 21st. The shares were purchased at an average cost of $17.53 per share, with a total value of $87,650.00. Following the acquisition, the director owned 10,000 shares of the company’s stock, valued at approximately $175,300. This trade represents a 100.00% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
SRH Total Return Fund Price Performance
Shares of STEW opened at $17.74 on Friday. SRH Total Return Fund, Inc. has a 1 year low of $16.55 and a 1 year high of $18.67. The firm has a fifty day moving average of $17.49 and a 200-day moving average of $17.85.
SRH Total Return Fund Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, July 24th will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.80 annualized dividend and a dividend yield of 4.5%.
Hedge Funds Weigh In On SRH Total Return Fund
SRH Total Return Fund Company Profile
SRH Total Return Fund (NYSE: STEW) is a diversified closed-end management investment company seeking high total return through a combination of income and capital appreciation. The fund pursues its objective by investing primarily in income-producing securities such as corporate bonds, convertible securities, preferred stocks and dividend-paying common stocks.
Portfolio managers employ active credit analysis and duration management to navigate changing market conditions and capture yield opportunities across both investment-grade and high-yield segments.
Featured Articles
- Five stocks we like better than SRH Total Return Fund
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for SRH Total Return Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SRH Total Return Fund and related companies with MarketBeat.com's FREE daily email newsletter.
